Results of a phase 3 trial published in The Lancet Oncology have confirmed that the drug abiraterone acetate (marketed as Zytiga) offers a significant survival benefit to patients with castration-resistant prostate cancer, ...
Sep 17, 2012
People who have a history of self-harm are more than three times as likely to die prematurely as the general population, and not just from the obvious causes, with deaths due to natural causes at least two times greater than ...
Sep 17, 2012
The heart health of millions of Europeans is still at risk because of the persistently high trans fatty acid content of certain fast and convenience foods, indicates research published in the online journal BMJ Open.
Sep 17, 2012
Cancer and chronic disease account for almost half of gradual deaths in European Union countries, suggests research published online in BMJ Supportive & Palliative Care.
Sep 17, 2012
(Medical Xpress)—Research carried out at the University of South Carolina has identified novel mechanisms through which dioxin, a well-known environmental contaminant, can alter physiological functions, according to a study ...
Sep 17, 2012
The power of taxane-based chemotherapy drugs are misunderstood and potentially underestimated, according to researchers at Weill Cornell Medical College in the September 15 issue of the journal Cancer Research.
Sep 17, 2012
In the first clinical trial to demonstrate an effective treatment for constant, disabling cough among people with idiopathic pulmonary fibrosis (IPF), researchers at the Johns Hopkins University School of Medicine found that ...
Sep 17, 2012
A new study that identifies ways to reduce the factors that lead to an asthma attack gives hope to asthma sufferers. A UCSF researcher and his colleagues believe they have found a way to help asthma sufferers by impeding ...
Sep 17, 2012
